ReNeuron Group to begin stem cell treatment of critical limb ischaemia

ReNeuron Group has received regulatory approval to begin the first phase of a clinical trial in the UK for the company's ReN009 stem cell therapy treatment for critical limb ischaemia.

http://www.livecharts.co.uk/share_prices/ReNeuron-Group-to-begin-stem-cell-treatment-o-news20785235.html